These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9831466)
1. Truncated presenilin 2 derived from differentially spliced mRNA does not affect the ratio of amyloid beta-peptide 1-42/1-40. Grünberg J; Walter J; Eckman C; Capell A; Schindzielorz A; Younkin S; Mehta N; Hardy J; Haass C Neuroreport; 1998 Oct; 9(14):3293-9. PubMed ID: 9831466 [TBL] [Abstract][Full Text] [Related]
2. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42. Tomita T; Tokuhiro S; Hashimoto T; Aiba K; Saido TC; Maruyama K; Iwatsubo T J Biol Chem; 1998 Aug; 273(33):21153-60. PubMed ID: 9694871 [TBL] [Abstract][Full Text] [Related]
3. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios. Walker ES; Martinez M; Brunkan AL; Goate A J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477 [TBL] [Abstract][Full Text] [Related]
4. Effects of presenilin N-terminal fragments on production of amyloid beta peptide and accumulation of endogenous presenilins. Shirotani K; Takahashi K; Tabira T Neurosci Lett; 1999 Feb; 262(1):37-40. PubMed ID: 10076867 [TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of presenilin 2 endoproteolytic C-terminal fragments. Tekirian TL; Merriam DE; Marshansky V; Miller J; Crowley AC; Chan H; Ausiello D; Brown D; Buxbaum JD; Xia W; Wasco W Brain Res Mol Brain Res; 2001 Nov; 96(1-2):14-20. PubMed ID: 11731004 [TBL] [Abstract][Full Text] [Related]
6. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants. Saura CA; Tomita T; Soriano S; Takahashi M; Leem JY; Honda T; Koo EH; Iwatsubo T; Thinakaran G J Biol Chem; 2000 Jun; 275(22):17136-42. PubMed ID: 10748144 [TBL] [Abstract][Full Text] [Related]
7. Monogenic determinants of familial Alzheimer's disease: presenilin-2 mutations. Renbaum P; Levy-Lahad E Cell Mol Life Sci; 1998 Sep; 54(9):910-9. PubMed ID: 9791533 [TBL] [Abstract][Full Text] [Related]
8. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Leimer U; Lun K; Romig H; Walter J; Grünberg J; Brand M; Haass C Biochemistry; 1999 Oct; 38(41):13602-9. PubMed ID: 10521267 [TBL] [Abstract][Full Text] [Related]
9. Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. Oyama F; Sawamura N; Kobayashi K; Morishima-Kawashima M; Kuramochi T; Ito M; Tomita T; Maruyama K; Saido TC; Iwatsubo T; Capell A; Walter J; Grünberg J; Ueyama Y; Haass C; Ihara Y J Neurochem; 1998 Jul; 71(1):313-22. PubMed ID: 9648880 [TBL] [Abstract][Full Text] [Related]
10. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Tomita T; Maruyama K; Saido TC; Kume H; Shinozaki K; Tokuhiro S; Capell A; Walter J; Grünberg J; Haass C; Iwatsubo T; Obata K Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2025-30. PubMed ID: 9050898 [TBL] [Abstract][Full Text] [Related]
11. Subcellular compartment and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2. Iwata H; Tomita T; Maruyama K; Iwatsubo T J Biol Chem; 2001 Jun; 276(24):21678-85. PubMed ID: 11283011 [TBL] [Abstract][Full Text] [Related]
12. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Pradier L; Carpentier N; Delalonde L; Clavel N; Bock MD; Buée L; Mercken L; Tocqué B; Czech C Neurobiol Dis; 1999 Feb; 6(1):43-55. PubMed ID: 10078972 [TBL] [Abstract][Full Text] [Related]
13. The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on abeta42 amyloid peptide formation. Jacobsen H; Reinhardt D; Brockhaus M; Bur D; Kocyba C; Kurt H; Grim MG; Baumeister R; Loetscher H J Biol Chem; 1999 Dec; 274(49):35233-9. PubMed ID: 10575009 [TBL] [Abstract][Full Text] [Related]
14. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202 [TBL] [Abstract][Full Text] [Related]
15. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Moehlmann T; Winkler E; Xia X; Edbauer D; Murrell J; Capell A; Kaether C; Zheng H; Ghetti B; Haass C; Steiner H Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8025-30. PubMed ID: 12048239 [TBL] [Abstract][Full Text] [Related]
16. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510 [TBL] [Abstract][Full Text] [Related]
17. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. Lee MK; Slunt HH; Martin LJ; Thinakaran G; Kim G; Gandy SE; Seeger M; Koo E; Price DL; Sisodia SS J Neurosci; 1996 Dec; 16(23):7513-25. PubMed ID: 8922407 [TBL] [Abstract][Full Text] [Related]